VIRUSLI GEPATIT C TURI BILAN KASALLANGAN TUG‘ISH YOSHIDAGI AYOLLARDA BIOKIMYOVIY MARKERLARNING DIAGNOSTIK AHAMIYATI
Article Sidebar
Main Article Content
Abstract:
Virusli gepatit C (HCV) — RNA tutuvchi virus bo‘lib, asosan jigar hujayralarini zararlaydi va surunkali gepatit, jigar fibrozlari hamda siroz holatlariga olib keladi. HCV bilan zararlanish ko‘p hollarda yashirin kechadi, bu esa kasallikni erta bosqichda aniqlashni qiyinlashtiradi. Shu sababli biokimyoviy markerlarni o‘rganish va ularni diagnostik jarayonda qo‘llash muhim ahamiyat kasb etadi.
Article Details
How to Cite:
References:
Alter, M. J. (2007). Epidemiology of hepatitis C virus infection. World Journal of Gastroenterology, 13(17), 2436–2441.
European Association for the Study of the Liver. (2020). EASL recommendations on treatment of hepatitis C 2020. Journal of Hepatology, 73(5), 1170–1218.
Ghany, M. G., & Morgan, T. R. (2024). Hepatitis C guidance 2024 update: Diagnosis, management, and treatment. Hepatology, 80(3), 1021–1044.
Khodjaeva, G. N. (2022). Gĕpatit C virusining biokimyoviy va immunologik ko‘rsatkichlariga ta’siri. O‘zbekiston Tibbiyoti Jurnali, 4, 45–51.
Pawlotsky, J. M. (2016). Hepatitis C virus resistance to direct-acting antiviral drugs in interferon-free regimens. Gastroenterology, 151(1), 70–86.
Ruxton, C. (2016). Tea: Hydration and other health benefits. Primary Health Care, 26(8), 34–42. https://doi.org/10.7748/phc.2016.e1162
WHO. (2024). Hepatitis C: Key Facts. World Health Organization. Retrieved from https://www.who.int/news-room/fact-sheets/detail/hepatitis-c
Zhaborova, S. M. (2022). Gepatit C da biokimyoviy markerlarning diagnostikadagi ahamiyati. Tibbiyotda Ilmiy Tadqiqotlar, 5, 39–44.